NCT03049605

Brief Summary

This study are to:

  • Evaluate effect of magnetic therapy on peripheral neuropathy in diabetic patients.
  • Evaluate effect of laser therapy on peripheral neuropathy in diabetic patients.
  • Compare effects of magnetic therapy with that of laser therapy on peripheral neuropathy in diabetic patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for phase_2 diabetes

Timeline
Completed

Started Jan 2014

Typical duration for phase_2 diabetes

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 25, 2014

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 8, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 10, 2017

Completed
Last Updated

February 10, 2017

Status Verified

February 1, 2017

Enrollment Period

11 months

First QC Date

February 8, 2017

Last Update Submit

February 9, 2017

Conditions

Keywords

Neuropathies laser and magnetic therapy

Outcome Measures

Primary Outcomes (1)

  • Motor and sensory conduction velocity of the lower limb nerves

    it is used for measuring motor and sensory conduction velocity: For this purpose nerve conduction studies (NCSs) will be performed for all patients including evaluation of bilateral peroneal and tibia motor nerves and sural sensory nerves (Asad 2009). Patients with NCV from 33-48m /sec will be recruited in this study (Pericz and Cvetkovic 2006 , and Graak 2009). All measurement will be done at stander room temperature of 25 c. The skin temperature of the leg was maintained at 37á´„. (Asad et al 2009).

    30-45 minutes

Study Arms (3)

Magnetic Therapy

EXPERIMENTAL

Twenty five patient were exposed to low intensity pulsed magnetic therapy with a frequency of 200 Hertz and intensity of 50 Gauss for 30 minutes / session for 2 times per week for 3 months .

Device: Magnetic therapy

Laser Therapy

EXPERIMENTAL

Twenty five patients were treated with 24 sessions of laser therapy at a rate of two sessions / week for three months. Each patient will be exposed to Helium neon infrared laser (850 nano-meter continuous wave mode from a comfortable prone lying position.

Device: laser therapy

Medical therapy

EXPERIMENTAL

Fifteen patients were received only medical treatment .

Drug: Only medical treatment

Interventions

low intensity pulsed magnetic therapy with a frequency of 200 Hertz and intensity of 50 Gauss . Magnetic device will be applied on each patient from a comfortable supine lying position. After the connection of appliance to electrical supply, the actions of PEMF will be directed and adjusted over lumbar spine, hip regions and calf muscles of both lower limbs.

Magnetic Therapy

laser therapy of Helium neon infrared laser (850 nano-meter) was used in continuous wave mode from a comfortable prone lying position on the whole plantar surface of the foot and the lumbo-sacral area by four points, and two points laterally to the spine.

Laser Therapy

Fifteen patients with diabetic peripheral neuropathy were treated with antidiabtic drugs and lyrica 150 milligram daily

Also known as: Lyrica 150 milligram
Medical therapy

Eligibility Criteria

Age35 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All diabetic patients with peripheral neuropathy will be selected to participate in this study.
  • Their age ranges from 35 to 65 years old.
  • All patients under medical control (optimal blood glucose). such as analgesic medications (e.g. opiates, anti-depressants, anticonvulsants and diabetic drugs to control blood glucose).

You may not qualify if:

  • Patients have DPN due to other causes than diabetes
  • Ulcers in either foot
  • Lack of blood sugar control
  • Other nervous system impairments
  • Visual problems
  • Unstable medical conditions
  • Pregnancy
  • Metallic implants
  • Alcohol or drug abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Bosi E, Conti M, Vermigli C, Cazzetta G, Peretti E, Cordoni MC, Galimberti G, Scionti L. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia. 2005 May;48(5):817-23. doi: 10.1007/s00125-005-1734-2. Epub 2005 Apr 15.

Related Links

MeSH Terms

Conditions

Diabetes Mellitus

Interventions

Magnetic Field TherapyLaser Therapy

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Officials

  • Enas F. Alananey, PhD

    Associate professor university of Dammam

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
By randomization of participants recruitment
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 8, 2017

First Posted

February 10, 2017

Study Start

January 25, 2014

Primary Completion

January 1, 2015

Study Completion

January 1, 2017

Last Updated

February 10, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share

The individuals date not shared but the final results comments will appear only